You are here
Clinical Trials: Urological Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Chronic Renal Failure
Intervention: Biological: Mesenchymal Stromal Cells
Sponsors: Monia Lorini; Mario Negri Institute for Pharmacological Research
Recruiting - verified September 2015
Intervention: Biological: Mesenchymal Stromal Cells
Sponsors: Monia Lorini; Mario Negri Institute for Pharmacological Research
Recruiting - verified September 2015
Conditions: Chronic Kidney Disease; Type 2 Diabetes
Intervention: Biological: Neo-Kidney Augment
Sponsors: RegenMed (Cayman) Ltd.; CTI Clinical Trial and Consulting Services
Not yet recruiting - verified April 2016
Intervention: Biological: Neo-Kidney Augment
Sponsors: RegenMed (Cayman) Ltd.; CTI Clinical Trial and Consulting Services
Not yet recruiting - verified April 2016
Conditions: Type 2 Diabetes; Impaired Renal Function
Interventions: Drug: Linagliptin; Drug: Placebo
Sponsors: George Washington University; Boehringer Ingelheim
Recruiting - verified April 2015
Interventions: Drug: Linagliptin; Drug: Placebo
Sponsors: George Washington University; Boehringer Ingelheim
Recruiting - verified April 2015
Condition: Uremia
Interventions: Other: SVFderived MSC transplantations; Drug: Basiliximab
Sponsor: Fuzhou General Hospital
Recruiting - verified November 2014
Interventions: Other: SVFderived MSC transplantations; Drug: Basiliximab
Sponsor: Fuzhou General Hospital
Recruiting - verified November 2014
Condition: Focal Segmental Glomerulosclerosis
Intervention: Biological: Intravenous injection
Sponsor: Royan Institute
Recruiting - verified November 2015
Intervention: Biological: Intravenous injection
Sponsor: Royan Institute
Recruiting - verified November 2015
Condition: Urinary Incontinence, Stress
Interventions: Biological: Stem Cells,Mesenchymal; Procedure: surgery (TVT)
Sponsor: Ain Shams Maternity Hospital
Recruiting - verified November 2015
Interventions: Biological: Stem Cells,Mesenchymal; Procedure: surgery (TVT)
Sponsor: Ain Shams Maternity Hospital
Recruiting - verified November 2015
Conditions: Urinary Incontinence; Stress; Urination Disorders; Urologic Diseases; Lower Urinary Tract Symptoms; Urological Manifestations
Intervention: Biological: autologous muscle-derived cells (AMDC)
Sponsor: Cook
Recruiting - verified April 2016
Intervention: Biological: autologous muscle-derived cells (AMDC)
Sponsor: Cook
Recruiting - verified April 2016
Conditions: Renal Artery Stenosis; Ischemic Nephropathy; Renovascular Disease; Chronic Kidney Disease
Interventions: Drug: Mesenchymal stem cell; Procedure: Mesenchymal stem cell delivery with stent placement
Sponsors: Mayo Clinic; University of Mississippi Medical Center; University of Alabama at Birmingham
Recruiting - verified October 2015
Interventions: Drug: Mesenchymal stem cell; Procedure: Mesenchymal stem cell delivery with stent placement
Sponsors: Mayo Clinic; University of Mississippi Medical Center; University of Alabama at Birmingham
Recruiting - verified October 2015
Condition: Urinary Incontinence
Interventions: Procedure: Myoblast Transplantation; Biological: Neonatal Cystourethroscope Injection
Sponsors: Al-Azhar University; Cairo University; Affiliated Hospital to Academy of Military Medical Sciences
Recruiting - verified February 2014
Interventions: Procedure: Myoblast Transplantation; Biological: Neonatal Cystourethroscope Injection
Sponsors: Al-Azhar University; Cairo University; Affiliated Hospital to Academy of Military Medical Sciences
Recruiting - verified February 2014
Condition: Urinary Incontinence
Intervention: Biological: Autologous Muscle Progenitor Cells
Sponsor: Gopal Badlani, MD
Recruiting - verified March 2014
Intervention: Biological: Autologous Muscle Progenitor Cells
Sponsor: Gopal Badlani, MD
Recruiting - verified March 2014
